Modified peptide nucleic acid (PNA) molecules
US6548651B1 · kind B1 · utility
24Cited by
3References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 12, 2000 |
| Grant date | Apr 15, 2003 |
| Priority date | — |
| Expiry date | Nov 4, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/3513
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel drugs which may be used in combating infectious micro-organisms, particularly bacteria. More specifically, the invention relates to peptide nucleic acid (PNA) sequences that are modified by conjugating cationic peptides to the PNA moiety in order to obtain novel PNA molecules that exhibit enhanced anti-infective properties.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.